Clemens BOTHE
3Patents
1h-index
30Co-inventors
44Inventor score
Filing activity: Jun 19, 2014 → Nov 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10442773B2 | Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration | Human Necessities | 1 | Active |
| US12138256B2 | Treatment of cardiopulmonary disorders | Human Necessities | 0 | Active |
| US12202805B2 | Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.